SwineCast Industry

Emerging Issues in Antibiotic Resistance Linked to Use in Food Animals

Emerging Issues in Antibiotic Resistance Linked to Use in Food AnimalsEmerging Issues in Antibiotic Resistance Linked to Use in Food Animals Dr. Peter Davies, College of Veterinary Medicine, University of Minnesota, reviews emerging issues in antibiotic resistance linked to use in food animals. Dr. Davies highlights work Environmental Antibiotic Resistome. Key take aways: 1) Increasing scrutiny of antibiotic use in food animals will not go away; 2) More ‘issue management’ in response to descriptive findings of AMR genes/bacteria in food animals and retail products; 3) Mostly without direct links to public health impact; 4) Proactive approaches to ensure customers and critics of 'appropriate uses'; and 5) Get on board the ‘antibiotic stewardship’ train [video].

Boehringer Ingelheim Science In Practice Reception

Science In Practice ReceptionScience In Practice Reception Boehringer Ingelheim remembered Dr. Bob Morrison in their pre-Allen D. Leman Conference Science In Practice Reception. Additionally, Dr. Bob Thompson, PIC, received the the Science in Practice Award [video].

Dr. Morrison As A Great Academic, Leader, Teacher, And Host

Tribute to Dr. Bob MorrisonTribute to Dr. Bob Morrison Dr. Trevor Ames and Dr. Gordon Spronk share their thoughts about Dr. Morrison, as a great academic, leader, teacher, and host [video].

Comparison of Intestinal Lesions

Comparison of intestinal lesions between Enterisol® Ileitis and Porcilis® Ileitis using a Lawsonia intracellularis mucosal homogenate seeder pig challenge modelComparison of intestinal lesions between Enterisol® Ileitis and Porcilis® Ileitis using a Lawsonia intracellularis mucosal homogenate seeder pig challenge model Dr. Jessica Seate, Boehringer Ingelheim Vetmedica, Inc, presents research on a comparison of intestinal lesions between Enterisol® Ileitis and Porcilis® Ileitis using a Lawsonia intracellularis mucosal homogenate seeder pig challenge model. Dr. Seate concludes with a summary that shares that IHC scores and histologic lesions (H&E) were lower for Enterisol® Ileitis group compared to the Porcilis® Ileitis and NVC groups, Enterisol® Ileitis had lowest percentage of PCR positives at necropsy, and IgG Lawsonia ELISA titers are not indicative of protective immunity [video].

Efficacy of Ingelvac PRRS® MLV

Efficacy of Ingelvac PRRS® MLV against a heterologous PRRSV 1-7-4 RFLP challengeEfficacy of Ingelvac PRRS® MLV against a heterologous PRRSV 1-7-4 RFLP challenge Dr. Reid Philips, Boehringer Ingelheim Vetmedica, Inc, shares insights on the efficacy of Ingelvac PRRS® MLV against a heterologous PRRSV 1-7-4 RFLP challenge. Key findings include: Ingelvac PRRS® MLV demonstrated significant protection against a virulent PRRSv ‘174’ challenge: 1) Significant reduction in viremia, 2) Significant reduction in lung lesions, and 3) Significant improvement in Daily Gain. Also, Ingelvac PRRS® MLV continues to demonstrate cross protection against new-emerging field strains [video].
Syndicate content